218 related articles for article (PubMed ID: 15622479)
1. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study.
Fukuda Y; Matsui T; Suzuki Y; Kanke K; Matsumoto T; Takazoe M; Matsumoto T; Motoya S; Honma T; Sawada K; Yao T; Shimoyama T; Hibi T
J Gastroenterol; 2004 Dec; 39(12):1158-64. PubMed ID: 15622479
[TBL] [Abstract][Full Text] [Related]
2. Adsorptive Monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease.
Kusaka T; Fukunaga K; Ohnishi K; Kosaka T; Tomita T; Yokoyama Y; Sawada K; Fukuda Y; Miwa H; Matsumoto T
J Clin Apher; 2004; 19(4):168-73. PubMed ID: 15597346
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
4. A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
Sands BE; Katz S; Wolf DC; Feagan BG; Wang T; Gustofson LM; Wong C; Vandervoort MK; Hanauer S
Gut; 2013 Sep; 62(9):1288-94. PubMed ID: 22760005
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory effects of adsorptive granulocyte and monocyte apheresis in patients with drug refractory Crohn's disease.
Nagase K; Fukunaga K; Kashiwamura S; Kono T; Kamikozuru K; Yokoyama Y; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kikuyama R; Kato K; Miwa H; Matsumoto T
Ther Apher Dial; 2011 Aug; 15(4):367-73. PubMed ID: 21884471
[TBL] [Abstract][Full Text] [Related]
6. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
[TBL] [Abstract][Full Text] [Related]
7. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
Kanke K; Nakano M; Hiraishi H; Terano A
Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
10. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
[TBL] [Abstract][Full Text] [Related]
11. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.
Ljung T; Thomsen OØ; Vatn M; Karlén P; Karlsen LN; Tysk C; Nilsson SU; Kilander A; Gillberg R; Grip O; Lindgren S; Befrits R; Löfberg R
Scand J Gastroenterol; 2007 Feb; 42(2):221-7. PubMed ID: 17327942
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy.
Kuwaki K; Mitsuyama K; Kaida H; Takedatsu H; Yoshioka S; Yamasaki H; Yamauchi R; Fukunaga S; Abe T; Tsuruta O; Torimura T
Cytotherapy; 2016 Feb; 18(2):291-9. PubMed ID: 26700210
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.
Yamamoto T; Umegae S; Kitagawa T; Yasuda Y; Yamada Y; Takahashi D; Mukumoto M; Nishimura N; Yasue K; Matsumoto K
Aliment Pharmacol Ther; 2004 Oct; 20(7):783-92. PubMed ID: 15379839
[TBL] [Abstract][Full Text] [Related]
16. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
[TBL] [Abstract][Full Text] [Related]
18. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
[TBL] [Abstract][Full Text] [Related]
19. Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease.
Tanida S; Mizoshita T; Ozeki K; Katano T; Tanaka M; Nishie H; Shimura T; Okamoto Y; Kubota E; Kataoka H; Joh T
Ther Apher Dial; 2018 Jun; 22(3):295-300. PubMed ID: 29790276
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis.
Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
Ther Apher Dial; 2008 Feb; 12(1):13-8. PubMed ID: 18257807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
